New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive ...

A renowned mountain guide revealed on Monday said that using xenon gas treatment and cutting-edge technology is not only expediting Mount Everest climbs but also minimizing environmental impact by ...

A surprising link between Alzheimer’s and cancer reveals that amyloid beta, a harmful protein in the brain, actually empowers the immune system. It strengthens T-cells’ energy production, helping them ...

Roche, which currently has investigational Alzheimer’s disease drug trontinemab in phase 3 trials, has secured FDA clearance of its blood-based biomarker test for the condition. The minimally invasive ...

Four British men have successfully completed a controversial high-speed expedition on Mount Everest, reaching the summit in just five days with help from xenon gas. The climbers—who are all former ...

Every few weeks, a 65-year-old man named Rick drives an hour and a half from his home in New Hampshire to Brigham and Women’s Hospital in Boston, where a nurse inserts a needle in his arm and a clear ...

Roche's Elecsys pTau181 test is the second blood-based biomarker test to receive FDA clearance for Alzheimer’s disease this year. - Sarah Silbiger/Getty Images The US Food and Drug Administration has ...

Richard J. Price receives funding from the National Institutes of Health and the UVA Focused Ultrasound Cancer Immunotherapy Center. Sound waves at frequencies above the threshold for human hearing ...

The effectiveness of eye-tracking technology in identifying people who have a genetic tendency to Alzheimer's disease, years before their symptoms show, has been highlighted in new research. Tests ...

Christina Ebey is no stranger to Alzheimer’s disease. In high school, her grandmother died from the disease. Thirty years later, Ebey is watching her aunt suffer from it. Her experiences led her to ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

Oct 13 (Reuters) - Roche Diagnostics (ROG.S), opens new tab said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's (LLY.N), opens new tab blood test as an aid in the ...